A Comparison of Cancer Incidences Between Dharmais Cancer Hospital and GLOBOCAN 2020: A Descriptive Study of Top 10 Cancer Incidences

B. Andinata, A. Bachtiar, P. Oktamianti, Jeremy Romeo Partahi, Mazaya Shafa Ainan Dini
{"title":"A Comparison of Cancer Incidences Between Dharmais Cancer Hospital and GLOBOCAN 2020: A Descriptive Study of Top 10 Cancer Incidences","authors":"B. Andinata, A. Bachtiar, P. Oktamianti, Jeremy Romeo Partahi, Mazaya Shafa Ainan Dini","doi":"10.33371/ijoc.v17i2.982","DOIUrl":null,"url":null,"abstract":"Background: : Cancer is one of the main causes of death and increased morbidity in every country in the world. According to Global Cancer Observatory (GLOBOCAN) 2020 data, it is estimated that 19.3 million new cancer cases and nearly 10.0 million cancer deaths occurred in the world in 2020. Based on the same data, it is estimated that 396,914 new cancer cases and nearly 234,511 cancer deaths are estimated to occur in Indonesia. Dharmais National Cancer Hospital (DNCH) as a national cancer center is a miniature of cancer data in Indonesia. For this reason, researchers want to compare whether the data on the number and types of cancer in DNCH are the same as those in GLOBOCAN 2020.Methods: This research is a descriptive analysis with secondary data collection methods taken from medical records. The sampling technique was total sampling, univariate data analysis, namely new cases of cancer patients for the January-December 2021 period which are 2,382 cases.Results: The results showed that the same order in both data was only found in the first, second, and seventh order, namely breast cancer, cervical cancer, and non-Hodgkin’s lymphoma, respectively. However, the percentage of new cases of breast cancer in RSKD is much higher (2.5-folds) than in GLOBOCAN.Conclusion: There are several differences between the data on new cancer cases in the two data, which can be caused because DNCH has complete facilities, both for diagnostic and curative purposes, and examinations such as IHC and bone scans are only available at certain hospitals and one of them is DNCH.","PeriodicalId":13489,"journal":{"name":"Indonesian Journal of Cancer","volume":"34 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indonesian Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33371/ijoc.v17i2.982","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: : Cancer is one of the main causes of death and increased morbidity in every country in the world. According to Global Cancer Observatory (GLOBOCAN) 2020 data, it is estimated that 19.3 million new cancer cases and nearly 10.0 million cancer deaths occurred in the world in 2020. Based on the same data, it is estimated that 396,914 new cancer cases and nearly 234,511 cancer deaths are estimated to occur in Indonesia. Dharmais National Cancer Hospital (DNCH) as a national cancer center is a miniature of cancer data in Indonesia. For this reason, researchers want to compare whether the data on the number and types of cancer in DNCH are the same as those in GLOBOCAN 2020.Methods: This research is a descriptive analysis with secondary data collection methods taken from medical records. The sampling technique was total sampling, univariate data analysis, namely new cases of cancer patients for the January-December 2021 period which are 2,382 cases.Results: The results showed that the same order in both data was only found in the first, second, and seventh order, namely breast cancer, cervical cancer, and non-Hodgkin’s lymphoma, respectively. However, the percentage of new cases of breast cancer in RSKD is much higher (2.5-folds) than in GLOBOCAN.Conclusion: There are several differences between the data on new cancer cases in the two data, which can be caused because DNCH has complete facilities, both for diagnostic and curative purposes, and examinations such as IHC and bone scans are only available at certain hospitals and one of them is DNCH.
达摩肿瘤医院与GLOBOCAN 2020癌症发病率比较:十大癌症发病率描述性研究
背景:癌症是世界各国死亡和发病率上升的主要原因之一。根据全球癌症观察站(GLOBOCAN) 2020年的数据,2020年全球估计有1930万新的癌症病例和近1000万癌症死亡。根据同样的数据,估计印度尼西亚将发生396,914例新的癌症病例和近234,511例癌症死亡。作为国家癌症中心的Dharmais国家癌症医院(DNCH)是印度尼西亚癌症数据的缩影。出于这个原因,研究人员想比较DNCH中癌症数量和类型的数据是否与GLOBOCAN 2020中的数据相同。方法:本研究采用描述性分析,采用病历资料二次资料收集方法。抽样方法为全抽样,单变量数据分析,即2021年1 - 12月新增癌症患者2382例。结果:结果显示,两组数据中相同的顺序仅在第一、第二和第七阶中发现,分别为乳腺癌、宫颈癌和非霍奇金淋巴瘤。然而,与GLOBOCAN相比,RSKD中乳腺癌新发病例的百分比要高得多(2.5倍)。结论:两份数据中关于新发癌症病例的数据存在一些差异,这可能是由于DNCH拥有完整的诊断和治疗设施,并且只有在某些医院才能进行IHC和骨扫描等检查,其中之一就是DNCH。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信